More than 20 topics will be covered, including COVID-19 and the heart, Mitraclip and repair techniques, AFib management, high risk PCI for left main disease and total occlusions, and mechanical devices to improve heart failure.
The cardiac pacemaker of the future could be powered by the heart itself, according to researchers in China. Current cardiac pacemakers use a battery power supply and leads to keep hearts beating regularly. Yi Zhiran and his group are investing batteryless powering and leadless pacing, harvesting kinetic energy from the heart to power the lifesaving device. The energy is harvested by the buckling of the encapsulated structure of the pacemaker, creating buckled piezoelectric energy.
Shekar will lead the department’s efforts to treat patients with cutting edge surgical approaches, train the next generation of cardiothoracic surgeons and move the field forward through rigorous research.
.Researchers from the University of Maryland School of Medicine (UMSOM) and their colleagues found that nearly 20 percent of patients with unexplained sudden cardiac death – most of whom were under age 50 – carried rare genetic variants. These variants likely raised their risk of sudden cardiac death.
Thanks to a grant from Edwards Lifesciences Foundation, nurses caring for underserved critically ill cardiac patients at 10 U.S. hospitals will participate in a cardiac-focused cohort of AACN Clinical Scene Investigator (CSI) Academy, a nurse leadership and innovation program from the American Association of Critical-Care Nurses.
Experts from Hackensack Meridian Jersey Shore University Medical Center’s Structural Heart Disease Program recently performed, to the program’s knowledge, New Jersey’s first transcatheter double heart valve replacement, combined with a procedure to improve blood flow in the heart. The three treatments were completed together during one visit to the academic medical center’s advanced hybrid operating room, to ensure the patient’s safety.
Hackensack Meridian Jersey Shore University Medical Center opened a new cardiac catheterization laboratory in February. The lab upgrades the academic medical center’s services treating heart disease.
New data released this week by Australian researchers reveals the impact of the COVID-19 lockdown period on aeromedical retrievals in rural and remote regions.
A small and inexpensive sensor, announced in Applied Physics Letters and based on an electrochemical system, could potentially be worn continuously by cardiac patients or others who require constant monitoring. A solution containing electrolyte substances is placed into a small circular cavity that is capped with a thin flexible diaphragm, allowing detection of subtle movements when placed on a patient’s chest. The authors suggest their sensor could be used for diagnosis of respiratory diseases.
Credentialed press representatives are invited to attend The Society of Thoracic Surgeons VIRTUAL 57th Annual Meeting. This interactive, fully digital experience—expected to be unlike anything that cardiothoracic surgery has experienced to date—will feature thought-provoking lectures, practice-changing science, and cutting-edge techniques and technologies.
Cleveland: Cleveland Clinic researchers have found that cryoballoon ablation as the initial treatment for atrial fibrillation is more effective than current standard-of-care management using medications. The study was published today in the New England Journal of Medicine.
University at Buffalo spinoff Cytocybernetics is developing a high-tech tool called CyberQ to rapidly assess whether or not investigational COVID-19 drugs have arrhythmogenic properties that can result in sudden cardiac death.
Surgeons at University Hospitals Cleveland Medical Center have improved the prognosis of several cardiac patients after emergency FDA approval of a diaphragm pacing device.
Hackensack Meridian Jersey Shore University Medical Center recently launched a Cardio-Oncology Program providing cancer patients and survivors access to cardiology and oncology specialists and advanced imaging services. L. Steven Zukerman, M.D., FACC, serves as medical director of the program, designed to minimize the impact of cancer treatments on patients’ hearts and provide continuing cardiac care to cancer survivors.
In an article published online on June 26 in the journal Heart Rhythm, lead author Raul Mitrani, M.D., and co-authors with the University of Miami Miller School of Medicine’s Division of Cardiovascular Medicine, examine the varied cardiovascular injuries and complications that patients who have recovered from the acute COVID-19 infection may experience largely based on evidence from other viral infections or inflammatory injury to the heart. The authors also recommend developing screening and tracking measures to detect cardiac injury and potentially mitigate long-term impact.
MacNeal Hospital is the first hospital in Illinois to participate in a national, randomized clinical trial using daily vital signs and lung pressure measurement to manage patients with congestive heart failure (CHF). The PROACTIVE-HF trial utilizes a new monitoring system, coupled with a pressure sensor, implanted directly into a blood vessel in the lung. This system provides information that is recorded and transmitted over a cellular or Wi-Fi connection to a patient’s provider, allowing for medication changes, if necessary, to prevent further health deterioration or hospitalization.
Atrial fibrillation ranks among the most common heart conditions, and episodes are difficult to predict. Researchers have proposed a way to define cardiac state and have studied the dynamics before the cardiac rhythm changes from normal sinus to AF rhythm and vice versa. The work, appearing in Chaos and based on critical transition theory, looks to provide an early warning for those with paroxysmal atrial fibrillation with potential implications for future wearable devices.
Iowa State University scientists restored the function of heart muscles in aging fruit flies, according to a newly published study. The genetic complex identified in the research could lead to new treatments for heart disease in humans.
Twice-yearly injections of an experimental cholesterol-lowering drug, inclisiran, were effective at reducing low-density lipoprotein (LDL) cholesterol, often called bad cholesterol, in patients already taking the maximum dose of statin drugs, according to data of the ORION-10 trial presented Saturday, Nov. 16, at the American Heart Association’s Scientific Sessions 2019.
Toxicological Sciences continues to deliver cutting-edge research in toxicology in the November 2019 issue. This issue features research on computational toxicology and databases, developmental and reproductive toxicology, and more.
When Mick Jagger received an artificial heart valve via catheter, he made the transcatheter replacement valve famous. Iconic “Dr. Y” made it possible. Ajit Yoganathan’s lab has tested every valve on the market for quality, and his analyses shaped the industry and its designs, including of the valve in Jagger’s chest.
A dual-acting osteoporosis drug. Minimally invasive mitral valve surgery. New treatment for peanut allergies. These are some of the innovations that will enhance healing and change healthcare in the coming year, according to a distinguished panel of doctors and researchers.
ANN ARBOR, Mich. — Mitral valve procedures are often not performed because of the standing belief that LVAD support resolves mitral regurgitation, due to better left heart performance. A new study in The Journal of Thoracic and Cardiovascular Surgery found when…
Hui Yang, Harold and Inge Marcus Career Associate Professor of Industrial and Manufacturing Engineering at Penn State, was awarded a $320,625 grant from the National Science Foundation (NSF) to study exactly how a process called glycosylation can cause proteins to disrupt the harmony of cell activity.